Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine
J. Pitcovski, N. Gruzdev, A. Abzach, C. Katz, R. Ben-Adiva, M. Brand Schwartz, I. Yadid, H. Haviv, I. Rapoport, I. Bloch, R. Shadmon, Z. Eitan, D. Eliyahu, T. Hillel, M. Laster, , E. Shahar
This paper develops an oral SARS-CoV-2 vaccine that induces neutralizing antibodies and cellular immune responses, and shows it can boost immunity from injected vaccines.
Vaccine · Feb 1, 2022Peer-reviewedImmunology